COVID-19 / Coronavirus

FDA Grants Fast Track Designation to 9MW2821

2024-02-27 22:00 677

SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces that its self-developed novel ADC drug targeting Nectin-4 (R&D Code: 9MW2821) has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administ...

Zhongchao Inc. Announces 1-for-10 Share Consolidation

2024-02-27 21:00 2028

SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held onTues...

Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology

2024-02-21 22:00 1124

SHANGHAI, Feb. 21, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, recently published the phase III study results of denosumab biosimilar (MW032) online in the international top journal of JAMA Oncology. This is the first recorded tria...

Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year

2024-02-21 18:00 2600

* Revenue of €426 million for FY2023, a 1% increase over FY 2022 * Despite challenging conditions, Lanvin Group grew revenue by 8% in APAC * Resiliency through creative transition at Lanvin brand helped improve sales trend in the second half of 2023 * Positive signals in the DTC channel, in...

Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro

2024-02-21 16:00 1177

PORTO, Portugal, Feb. 21, 2024 /PRNewswire/ -- A team of researchers from Germany, the USA, the UK, and Norway won the third edition of the BIAL Award in Biomedicine , a300,000 Euro prize promoted by the BIAL Foundation

FDA Grants Orphan Drug Designation to 9MW3011

2024-02-20 22:00 1015

SHANGHAI, Feb. 20, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that FDA has granted Orphan Drug Designation (ODD) to 9MW3011 (R&D code in the US: MWTX-003/DISC-3405) for the treatment of patients with polycythemia vera (P...

Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711

2024-02-20 22:00 1038

SHANGHAI, Feb. 20, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of B7-H3 targeting ADC (R&D code: 7MW3711) for advanced malignant solid tumor was approved by the U.S. Food and Drug Admi...

Mount Alvernia Hospital Elevates Holistic Healthcare with OutSystems

2024-02-20 14:00 1510

Using the low-code platform, the hospital's in-house developers saved half the time it typically takes to develop applications for staff, patients and visitors. SINGAPORE, Feb. 20, 2024 /PRNewswire/ -- Mount Alvernia Hospital has partnered with OutSystems, a global leader in high-performance low...

YS Biopharma Announces Appointment of New Directors

2024-02-14 20:50 3256

GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccin...

Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024

2024-02-08 21:00 2478

DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully onFebruary 8. MedLab is the largest exhibition of medical equipment in theMiddle East region, attracting visitors worldwide to experience the academic atmosphere ...

Aurora Cannabis Acquires MedReleaf Australia

2024-02-08 19:45 1300

NASDAQ | TSX: ACB * Aurora becomes the largest global medical cannabis company operating in nationally legal markets. * MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market. * Transaction is expected to be immediately a...

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

2024-02-07 19:00 1126

* Agreement marks an important milestone to advance the Company's intent to become a U.S.-based biotech  * Agreement provides for a strategic focus in advancing I-Mab's potential of differentiated oncology clinical assets and builds shareholder value by streamlining the operating model, reduc...

2024 Global Appeal Calls for Well-Informed Public to 'Break Chains of Discrimination' against Leprosy

2024-02-01 14:00 1322

TOKYO, Feb. 1, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative has partnered with the World Health Organization to co-host the launch of the 2024 Global Appeal to end stigma and discrimination against persons affected by leprosy at WHO headquarters inGeneva on January 31, 2024...

A Korean UV Sensor Manufacturer, Genicom Introduces Breakthrough Far UV & VUV Optical Sensor for Safe and Efficient Pathogen Control

2024-01-31 22:00 1170

SEOUL, South Korea, Jan. 31, 2024 /PRNewswire/ -- The COVID-19 pandemic is an ongoing challenge of emerging and re-emerging infectious pathogens. Ultraviolet (UV) has high energy in the wavelength range of 100 ~ 400nm and is used for sterilization, air purification, medical treatment, etc. by bre...

FRESH PET FOOD PROVEN CRUCIAL FOR LONG-TERM HEALTH AND FINANCIAL SAVINGS, REVEALS INDEPENDENT SMU STUDY

2024-01-30 09:05 1210

SINGAPORE, Jan. 29, 2024 /PRNewswire/ -- Recently, a new study, utilising PetCubes product, revealed insights into the changing pet food preferences among Singapore pet owners. In a comprehensive independent market study conducted by Singapore Management University (SMU) in 2022[1], a notable shif...

Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

2024-01-29 21:30 1209

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- SiRNA technology offers distinct advantages over conventional approaches, with the potential to target virtually any gene. This technology has emerged as a great strategy for treating a range of diseases, including cancer, viral infections, and genetic...

Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'

2024-01-24 20:00 1935

* Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' * Digitally enhance Seegene's automated diagnostic reagent development system with the integration of Microsoft Azure AI solutions * A ...

INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness

2024-01-24 08:22 1177

Global landscape analysis identifies strengths and gaps in R&D pipeline  to inform international pandemic preparedness efforts ROME and CAMBRIDGE, Mass., Jan. 24, 2024 /PRNewswire/ -- The INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating the devel...

Asian Smart Medical Online Exhibition 2024 Grand Opening

2024-01-18 11:08 1429

TAIPEI, Jan. 18, 2024 /PRNewswire/ -- Asian Smart Medical Online Exhibition (Medical Asia 2024) is a virtual and physical integration targeting Asian suppliers, importers, and exporters. It will be exhibited fromJanuary 17, 2024, toJune 30, 2024, and will be an excellent opportunity for exhibitor...

YS Biopharma Announces Changes to its Board Committees

2024-01-08 21:00 1135

GAITHERSBURG, Md., Jan. 8, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...

12345 ... 224